MedPath

Clinical efficacy of anagliptin administration in type 2 diabetic patients

Phase 4
Recruiting
Conditions
Type 2 Diabetes
Registration Number
JPRN-UMIN000011071
Lead Sponsor
Kuwana East Medical Center Cardiology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Out of above criteria

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath